JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barker, S. B.
Right arrow Articles by Wawzonek, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barker, S. B.
Right arrow Articles by Wawzonek, S.
Journal of Pharmacology And Experimental Therapeutics, Vol. 99, Issue 2, 202-214, 1950
Copyright © 1950 by American Society for Pharmacology and Experimental Therapeutics


EVALUATION OF AGENTS WITH THYROXINE-INHIBITING EFFECTS

S. B. Barker 1, C. E. Kiely Jr. 1, H. B. Dirks Jr. 1, H. M. Klitgaard 1, S. C. Wang 1, and S. Wawzonek 1

1 Departments of Physiology and Chemistry, State University of Iowa, Iowa City

Several substances have been tested for thyroxine-inhibiting action using the following criteria: (1) lowering the BMR of normal rats, (2) lowering the thyroxine-elevated BMR of thyroidectomized rats, (3) reversal of thyroxine depression of estrogen responsiveness.

Among the compounds showing some ability to overcome thyroxine effects were: Iodinated phenoxyacetic acids, 4-hydroxy- and 4-benzyloxy-3,5-diiodobenzoic acids and N-(4'-hydroxy-3',5'-diiodobenzoyl)-3,5-diiodotyrosine. In contrast, 3,5-diiodo-L-tyrosine and 3,5-dibromo-L-tyrosine showed no activity.

Submitted on February 28, 1950







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1950 by the American Society for Pharmacology and Experimental Therapeutics.